PS

Poonam Singh Rajput

Active Director Director DIN 10093063
DIN 10093063 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Poonam Singh Rajput

Data last updated:

Poonam Singh Rajput is a Director at Relisons Healthcare Private Limited (since 2023). Relisons Healthcare Private Limited reported revenue of ₹8,500 (FY 2025).

DIN 10093063
Primary Designation Director
First Appointment 29 Mar 2023
Oldest Company Age 3 yrs
Largest company Relisons Healthcare Private Limited · ₹8,500 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Relisons Healthcare Private Limited U86100MP2023PTC065029
Director29 Mar 20232023₹8,500 (FY 2025)Active

Board colleagues of Poonam Singh Rajput

Directorship timeline

Open interactive timeline →
Relisons Healthcare Private Limited
Premium access

Shareholding and investment profile for Poonam Singh Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Singh Rajput

Poonam Singh Rajput currently holds 1 directorship: Relisons Healthcare Private Limited (Director, since 29 Mar 2023, revenue ₹8,500 (FY 2025)).

Poonam Singh Rajput was first appointed on 29 Mar 2023 as Director at Relisons Healthcare Private Limited.

The current boards of Poonam Singh Rajput's companies include Navodit Rathore (Relisons Healthcare Private Limited), Vishal Mallusingh Baghele (Relisons Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available